Skip to main content

Table 2 Responses to selected survey questions

From: Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America

Question

Latin America (n=2,169)

Argentina (n=436)

Brazil (n=400)

Mexico (n=532)

Puerto Rico (n=401)

Venezuela (n=400)

Daytime symptom frequency, %

      

  Every day/most days

24

35

27

12

34

18

  1-2 days/week

22

25

20

20

15

29

  1-2 times/month

11

8

10

18

7

11

  No daytime symptoms

44

32

44

50

43

42

Nighttime symptom frequency, %

      

  Every night/most nights

20

28

24

9

26

14

  1-2 nights/week

16

20

16

16

15

18

  1-2 times/month

10

8

11

12

5

10

  No nighttime symptoms

53

45

50

62

53

58

Subjects with episodes in the past 12 months with asthma symptoms more frequent or more severe than normal, %

47

57

46

42

61

48

Median number of episodes

2

3

2

3

3

3

Subjects who agreed with the following statements, %

      

  Long-term control medicines should be taken every day

41

61

41

48

61

26

  Long-term control medicines are not necessary when asthma symptoms are not experienced regularly

65

55

67

54

59

72

  Quick relief medications can be used every day if needed

61

68

58

56

84

71

Subjects reporting ≥1 week of interrupted asthma controller medicine use, %

      

  <2 weeks

26

32

26

29

15

21

  3-4 weeks

9

10

8

14

9

10

  ≥1 month

61

49

52

52

71

65

GINA 2009 asthma control levels

      

  Well controlled, %

8

5

9

9

8

3

  Partly controlled, %

57

48

57

56

59

65

  Uncontrolled, %

35

57

34

35

33

32

  1. GINA=Global initiative for asthma.